asa guidelines for glp 1 The 2023 position on GLP-1 receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on ASA: Hold GLP-1 Agonists Before

Because theyre low in fat, theyre a good option for patients taking GLP-1 medications

A.ThieryJ

Just wondering if anyone has tried this protein powder before

Be sure to look for our new labels with the MADE IN USA SHIELD

It has been shown to repair tissue damage, even that caused by prolonged corticosteroid use

A Nature Medicine review published in January 2026 described GLP-1 medicines as "being prescribed to growing numbers of patients worldwide" for an expanding list of indications and noted that "new, more effective molecules with optimised pharmacokinetics produce greater weight loss and some may be more effective for various metabolic disorders, through incorporation of one or more additional peptide epitopes." The clinical pipeline includes 39 GLP-1 receptor agonist drugs in development across 34 companies, with only seven coming from the top 20 pharmaceutical firms